MHC class II restricted recognition of FMDV peptides by bovine T cells.
A putative synthetic vaccine for foot-and-mouth disease (FMDV15) has proved less successful in a host species, cattle, than predicted by results in a small-animal model. Possible reasons for this include non-recognition by T cells influenced by major histocompatibility complex (MHC)-linked immune response gene control. It is now possible to type for human leucocyte antigen (HLA) DR-like bovine MHC (BoLA) class II polymorphisms with a one-dimensional isoelectric focusing (IEF) technique. Using this method 14 unrelated cattle were selected with eight different BoLA class II IEF types. After immunization with FMDV15, 13 cattle generated a T-cell response to FMDV15. However, the fine specificity and magnitude of the response was related to BoLA class II type. The non-response by one animal and low response by two other animals were associated with two of the BoLA class II types. Response to the region 149-158 was immunodominant and animals which did not respond to this region had low responses to the whole peptide. Using FMDV-specific T-cell lines five BoLA class II types associated with responder animals were able to present FMDV15 in an MHC class II-restricted fashion, indicating that this peptide is capable of binding to different MHC class II molecules and may account for the broad response observed. The restriction patterns of the lines indicated that the IEF method does not distinguish all functional polymorphisms. At least two of the IEF-defined types could each be split into two distinct specificities and revealed that the three sets of animals with identical IEF types in fact expressed distinct restriction elements.
Glass
E J
EJ
AFRC Institute of Animal Physiology and Genetics Research, Roslin, U.K.
Oliver
R A
RA
Collen
T
T
Doel
T R
TR
Dimarchi
R
R
Spooner
R L
RL
D000818:Animals; D005537:Aphthovirus / Q000276:immunology*; D002417:Cattle / Q000276:immunology*; D002455:Cell Division / Q000276:immunology; D005802:Genes, MHC Class II / Q000276:immunology*; D007108:Immune Tolerance / Q000235:genetics; D008297:Male; D010455:Peptides / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology*; D014614:Vaccines, Synthetic / Q000276:immunology; D014765:Viral Vaccines / Q000276:immunology*
D010455:Peptides; D014614:Vaccines, Synthetic; D014765:Viral Vaccines